This was demonstrated in a study on 83 patients with late stage NSCLC [199] where the number of CTCs and of circulating lymphocytes (CD3+, CD4+, CD4+/CD8+ cells, and NK cells) were compared. Here, CD4 is linked to non-small cell lung carcinoma.